Capgras syndrome after use of synthetic cannabinoids: an adolescent case

Capgras Syndrome Due to Cannabinoids Use: A Case Report With Radiological Findings

“…Capgras syndrome associated with cannabis has been described mainly in male patients between 17 and 30 years old, either after chronic or acute cannabinoid consumption, which is consistent with the information described in this case [ 1 , 9 ].…”

“…Capgras syndrome is a part of the delusional misidentification syndromes. In this condition, the patient believes that identical individuals have impersonated the people close to them, leading to aggression or even homicide of their relatives [1][2][3][4]. Capgras syndrome was first described in 1923 by Joseph Capgras and Jean Reboul-Lachaux, who reported the case of a 53-year-old female patient, who assured that her children, husband, and later the local police, doctors, neighbors, and even herself were being replaced by doubles [5].…”

Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review

“…The full text of remaining 216 papers was searched, and a further 192 papers excluded due to not fulfilling the inclusion criteria (Fig 1). After abstraction and full text screening, a total of 24 articles were selected for review: 2 toxicology reports (Monte et al, 2017;Waugh et al, 2016), 4 casecontrol studies (Altintas et al, 2016;Bassir Nia et al, 2016;Shalit et al, 2016;Welter et al, 2017), 3 cross-sectional analyses (Glue et al, 2013;Manseau et al, 2017;Vallersnes et al, 2016) and 15 case reports (Barcelo et al, 2017;Benford and Caplan, 2011;Coppola and Mondola, 2017;Hurst et al, 2011;Johnson et al, 2011;Mahgoub and Young, 2017;Meijer et al, 2014;Muller et al, 2017;Oliveira et al, 2017;Oluwabusi et al, 2012;Ozer et al, 2016;Roberto et al, 2016;Rojek et al, 2017;Samaan et al, 2016; Van der Veer and Friday, 2011) ( Figure 1).…”

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

“…Ozer et al (75) described a case of an adolescent with a new-onset psychosis following inhalation of a mixture of SC called “Bonsai.” Olanzapine (10 mg daily) was prescribed and the subject was followed up 3 months after discharge without a recurrence of psychotic symptoms (75).…”

“…From a therapeutic perspective, benzodiazepines are useful for managing anxiety, agitation, and seizure risk, together with a supportive/symptomatic therapy (1, 7, 30, 32, 36, 39, 41, 46, 48, 59–61, 71, 79, 81). Olanzapine, clozapine, quetiapine, and aripiprazole represent the main prescribed antipsychotic treatments in SC-induced psychoses (1, 7, 37, 50, 57, 60, 62, 65–67, 70, 75, 85, 86), while haloperidol, risperidone, and paliperidone have been prescribed/used in isolated cases (45, 53, 63, 73, 85).…”